Cormorant Private Healthcare Fund Iii Lp - Net Worth and Insider Trading
Cormorant Private Healthcare Fund Iii Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cormorant Private Healthcare Fund Iii Lp owns 16 companies in total, including Prometheus Biosciences Inc (RXDX) , Rain Oncology Inc (RAIN) , and Olema Pharmaceuticals inc (OLMA) among others .
Insider Ownership Summary of Cormorant Private Healthcare Fund Iii Lp
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| RXDX | Prometheus Biosciences Inc | 2021-03-11 | 10 percent owner |
| RAIN | Rain Oncology Inc | 2021-04-22 | 10 percent owner |
| OLMA | Olema Pharmaceuticals inc | 2020-11-18 | 10 percent owner |
 | | 2021-10-07 | 10 percent owner |
| | 2021-06-24 | 10 percent owner |
| | 2021-07-28 | 10 percent owner |
| | 2023-04-20 | 10 percent owner |
| | 2021-03-25 | 10 percent owner |
| | 2021-06-23 | 10 percent owner |
| | 2023-03-30 | 10 percent owner |
| | 2021-06-16 | 10 percent owner |
| | 2021-10-20 | 10 percent owner |
| | 2021-09-14 | 10 percent owner |
| | 2023-03-03 | 10 percent owner |
| | 2023-10-02 | 10 percent owner |
| | 2023-10-23 | 10 percent owner |
Cormorant Private Healthcare Fund Iii Lp Trading Performance
Cormorant Private Healthcare Fund Iii Lp Ownership Network
Ownership Network List of Cormorant Private Healthcare Fund Iii Lp
Ownership Network Relation of Cormorant Private Healthcare Fund Iii Lp
Cormorant Private Healthcare Fund Iii Lp Owned Company Details
What does Prometheus Biosciences Inc do?
Who are the key executives at Prometheus Biosciences Inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Prometheus Biosciences Inc. Other key executives at Prometheus Biosciences Inc include Chief Financial Officer Keith W Marshall , director & President and CEO Mark C. Mckenna , and 10 percent owner Cedars Sinai Intellectual Property Co .
Prometheus Biosciences Inc (RXDX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Prometheus Biosciences Inc (RXDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prometheus Biosciences Inc (RXDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Prometheus Biosciences Inc (RXDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prometheus Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Rain Oncology Inc do?
Who are the key executives at Rain Oncology Inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Rain Oncology Inc. Other key executives at Rain Oncology Inc include 10 percent owner Kevin C Tang , Principal Fin. & Acc. Officer Josephine Bruce , and 10 percent owner Tang Capital Partners Lp .
Rain Oncology Inc (RAIN) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Iii Lp made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net sale of 173,973 shares made by Kevin C Tang ,
In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 173,973 shares of Rain Oncology Inc (RAIN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 173,973 shares.
Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rain Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Olema Pharmaceuticals inc do?
Who are the key executives at Olema Pharmaceuticals inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include director & Chief Technology Officer Cyrus Harmon , director & President and CEO Sean Bohen , and Chief Development Officer David C. Myles .
Olema Pharmaceuticals inc (OLMA) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Iii Lp made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 191,393 shares made by Cyrus Harmon , a net sale of 3,050,761 shares made by G. Walmsley Graham , and a net sale of 2,400,000 shares made by Paradigm Biocapital Advisors Lp .
In summary, during the past 3 months, insiders sold 0 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,541,447 shares of Olema Pharmaceuticals inc (OLMA) were sold and 1,000,761 shares were bought by its insiders, resulting in a net sale of 5,540,686 shares.
Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Olema Pharmaceuticals inc Insider Transactions
- Download to Excel(.xls)
What does Pyxis Oncology Inc do?
Who are the key executives at Pyxis Oncology Inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Pyxis Oncology Inc. Other key executives at Pyxis Oncology Inc include Chief Financial Officer Pamela Ann Connealy , Chief Accounting Officer Jitendra Wadhane , and director & Chief Executive Officer Lara Sullivan .
Pyxis Oncology Inc (PYXS) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Iii Lp made no insider transaction in Pyxis Oncology Inc (PYXS). Other recent insider transactions involving Pyxis Oncology Inc (PYXS) include a net purchase of 88,850 shares made by Pamela Ann Connealy ,
In summary, during the past 3 months, insiders sold 0 shares of Pyxis Oncology Inc (PYXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pyxis Oncology Inc (PYXS) were sold and 88,850 shares were bought by its insiders, resulting in a net purchase of 88,850 shares.
Pyxis Oncology Inc (PYXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pyxis Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Elevation Oncology Inc do?
Who are the key executives at Elevation Oncology Inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Elevation Oncology Inc. Other key executives at Elevation Oncology Inc include CHIEF FINANCIAL OFFICER Tammy Furlong , 10 percent owner Robert J Adelman , and 10 percent owner Venbio Global Strategic Gp Iii, L.p. .
Elevation Oncology Inc (ELEV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Elevation Oncology Inc (ELEV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elevation Oncology Inc (ELEV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Elevation Oncology Inc (ELEV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Elevation Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Icosavax Inc do?
Who are the key executives at Icosavax Inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Icosavax Inc. Other key executives at Icosavax Inc include director & Chief Executive Officer Adam K. Simpson , Chief Medical Officer Niranjan Kanesa-thasan , and Chief Financial Officer Thomas Joseph Russo .
Icosavax Inc (ICVX) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Iii Lp made no insider transaction in Icosavax Inc (ICVX). Other recent insider transactions involving Icosavax Inc (ICVX) include a net sale of 182,205 shares made by Adam K. Simpson , a net sale of 16,693 shares made by Cassia Cearley , and a net sale of 15,183 shares made by Thomas Joseph Russo .
In summary, during the past 3 months, insiders sold 0 shares of Icosavax Inc (ICVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 225,965 shares of Icosavax Inc (ICVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,965 shares.
Icosavax Inc (ICVX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Icosavax Inc Insider Transactions
- Download to Excel(.xls)
What does Immuneering Corp do?
Who are the key executives at Immuneering Corp?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Immuneering Corp. Other key executives at Immuneering Corp include 10 percent owner Cormorant Asset Management, Lp , Vice President & Finance Mallory Morales , and Chief Business Officer Harold Eugene Brakewood .
Immuneering Corp (IMRX) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Iii Lp made no insider transaction in Immuneering Corp (IMRX). Other recent insider transactions involving Immuneering Corp (IMRX) include a net sale of 1,309,091 shares made by Cormorant Asset Management, Lp , a net purchase of 100,000 shares made by Peter Feinberg , and a net purchase of 57,965 shares made by Ann E Berman .
In summary, during the past 3 months, insiders sold 0 shares of Immuneering Corp (IMRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,309,091 shares of Immuneering Corp (IMRX) were sold and 197,083 shares were bought by its insiders, resulting in a net sale of 1,112,008 shares.
Immuneering Corp (IMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immuneering Corp Insider Transactions
- Download to Excel(.xls)
What does Design Therapeutics Inc do?
Who are the key executives at Design Therapeutics Inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Design Therapeutics Inc. Other key executives at Design Therapeutics Inc include director & President and CEO Joao Md Siffert , director & 10 percent owner Simeon George , and 10 percent owner Sr One Capital Fund I Aggregator Lp .
Design Therapeutics Inc (DSGN) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Iii Lp made no insider transaction in Design Therapeutics Inc (DSGN). Other recent insider transactions involving Design Therapeutics Inc (DSGN) include a net sale of 814,874 shares made by Arsani William , a net purchase of 26,965 shares made by John P. Schmid , and a net sale of 3,806 shares made by Deepa Prasad .
In summary, during the past 3 months, insiders sold 0 shares of Design Therapeutics Inc (DSGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 818,680 shares of Design Therapeutics Inc (DSGN) were sold and 28,265 shares were bought by its insiders, resulting in a net sale of 790,415 shares.
Design Therapeutics Inc (DSGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Design Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Monte Rosa Therapeutics Inc do?
Who are the key executives at Monte Rosa Therapeutics Inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Monte Rosa Therapeutics Inc. Other key executives at Monte Rosa Therapeutics Inc include Principal Accounting Officer Edmund Dunn , 10 percent owner Versant Venture Capital Vi, L.p. , and General Counsel Philip Nickson .
Monte Rosa Therapeutics Inc (GLUE) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Iii Lp made no insider transaction in Monte Rosa Therapeutics Inc (GLUE). Other recent insider transactions involving Monte Rosa Therapeutics Inc (GLUE) include a net sale of 1,857,674 shares made by Versant Venture Capital Vi, L.p. , a net sale of 4,879 shares made by Edmund Dunn , and a net purchase of 10,000 shares made by Chandra P. Leo .
In summary, during the past 3 months, insiders sold 2,062 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 10,000 shares, with a net purchase of 7,938 shares. During the past 18 months, 1,862,553 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 1,852,553 shares.
Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monte Rosa Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Biomea Fusion Inc do?
Who are the key executives at Biomea Fusion Inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Biomea Fusion Inc. Other key executives at Biomea Fusion Inc include Chief Financial Officer Franco Valle , Chief Medical Officer Juan Pablo Frias , and 10 percent owner A2a Pharmaceuticals, Inc. .
Biomea Fusion Inc (BMEA) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Iii Lp made no insider transaction in Biomea Fusion Inc (BMEA). Other recent insider transactions involving Biomea Fusion Inc (BMEA) include a net purchase of 12,509 shares made by Franco Valle , and a net purchase of 10,000 shares made by Hitchcock Michael J.m. .
In summary, during the past 3 months, insiders sold 0 shares of Biomea Fusion Inc (BMEA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biomea Fusion Inc (BMEA) were sold and 22,509 shares were bought by its insiders, resulting in a net purchase of 22,509 shares.
Biomea Fusion Inc (BMEA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biomea Fusion Inc Insider Transactions
- Download to Excel(.xls)
What does Verve Therapeutics Inc do?
Who are the key executives at Verve Therapeutics Inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Verve Therapeutics Inc. Other key executives at Verve Therapeutics Inc include Chief Administrative Officer Joan Nickerson , Chief Financial Officer Allison Dorval , and director & 10 percent owner & Chief Executive Officer Sekar Kathiresan .
Verve Therapeutics Inc (VERV) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Iii Lp made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net purchase of 73,319 shares made by Andrew D. Ashe , a net sale of 4,291 shares made by Joan Nickerson , and a net sale of 3,905 shares made by Allison Dorval .
In summary, during the past 3 months, insiders sold 24,054 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 24,054 shares. During the past 18 months, 26,123 shares of Verve Therapeutics Inc (VERV) were sold and 76,000 shares were bought by its insiders, resulting in a net purchase of 49,877 shares.
Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verve Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Ventyx Biosciences Inc do?
Who are the key executives at Ventyx Biosciences Inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Ventyx Biosciences Inc. Other key executives at Ventyx Biosciences Inc include Chief Scientific Officer John Nuss , director & Chief Executive Officer Raju Mohan , and Chief Financial Officer Martin Auster .
Ventyx Biosciences Inc (VTYX) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Iii Lp made no insider transaction in Ventyx Biosciences Inc (VTYX). Other recent insider transactions involving Ventyx Biosciences Inc (VTYX) include a net sale of 55,446 shares made by John Nuss , a net purchase of 436,828 shares made by Raju Mohan , and a net sale of 6,944 shares made by Christopher W Krueger .
In summary, during the past 3 months, insiders sold 1,887 shares of Ventyx Biosciences Inc (VTYX) in total and bought 0 shares, with a net sale of 1,887 shares. During the past 18 months, 126,967 shares of Ventyx Biosciences Inc (VTYX) were sold and 630,000 shares were bought by its insiders, resulting in a net purchase of 503,033 shares.
Ventyx Biosciences Inc (VTYX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ventyx Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Tyra Biosciences Inc do?
Who are the key executives at Tyra Biosciences Inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Tyra Biosciences Inc. Other key executives at Tyra Biosciences Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , Chief Financial Officer Alan Fuhrman , and director & Chief Executive Officer Todd Harris .
Tyra Biosciences Inc (TYRA) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Iii Lp made no insider transaction in Tyra Biosciences Inc (TYRA). Other recent insider transactions involving Tyra Biosciences Inc (TYRA) include a net sale of 125,393 shares made by Daniel Bensen , a net sale of 265,401 shares made by Nina S Kjellson , and a net sale of 250,000 shares made by Todd Harris .
In summary, during the past 3 months, insiders sold 0 shares of Tyra Biosciences Inc (TYRA) in total and bought 1,211,198 shares, with a net purchase of 1,211,198 shares. During the past 18 months, 640,794 shares of Tyra Biosciences Inc (TYRA) were sold and 2,441,379 shares were bought by its insiders, resulting in a net purchase of 1,800,585 shares.
Tyra Biosciences Inc (TYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tyra Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Ambrx Biopharma Inc do?
Who are the key executives at Ambrx Biopharma Inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Ambrx Biopharma Inc. Other key executives at Ambrx Biopharma Inc include 10 percent owner Cormorant Asset Management, Lp , Chief Financial Officer Sonja Nelson , and director & President and CEO Daniel J. O'connor .
Ambrx Biopharma Inc (AMAM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ambrx Biopharma Inc (AMAM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ambrx Biopharma Inc (AMAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ambrx Biopharma Inc (AMAM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ambrx Biopharma Inc Insider Transactions
- Download to Excel(.xls)
What does MoonLake Immunotherapeutics do?
Who are the key executives at MoonLake Immunotherapeutics?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of MoonLake Immunotherapeutics. Other key executives at MoonLake Immunotherapeutics include director & 10 percent owner Biotechnology Value Fund L P , director & Chief Executive Officer Santos Da Silva Jorge , and Chief Scientific Officer Kristian Reich .
MoonLake Immunotherapeutics (MLTX) Insider Trades Summary
Over the past 18 months, Cormorant Private Healthcare Fund Iii Lp made no insider transaction in MoonLake Immunotherapeutics (MLTX). Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net sale of 200,000 shares made by Kristian Reich , a net sale of 184,740 shares made by Santos Da Silva Jorge , and a net sale of 2,000,000 shares made by Biotechnology Value Fund L P .
In summary, during the past 3 months, insiders sold 0 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,655,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,655,740 shares.
MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
MoonLake Immunotherapeutics Insider Transactions
- Download to Excel(.xls)
What does Ambrx Biopharma Inc do?
Who are the key executives at Ambrx Biopharma Inc?
Cormorant Private Healthcare Fund Iii Lp is the 10 percent owner of Ambrx Biopharma Inc. Other key executives at Ambrx Biopharma Inc include Chief Financial Officer Sonja Nelson , director & President and CEO Daniel J. O'connor , and 10 percent owner Cormorant Asset Management, Lp .
Ambrx Biopharma Inc (AMAM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Ambrx Biopharma Inc (AMAM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ambrx Biopharma Inc (AMAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Ambrx Biopharma Inc (AMAM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ambrx Biopharma Inc Insider Transactions
- Download to Excel(.xls)
Cormorant Private Healthcare Fund Iii Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Cormorant Private Healthcare Fund Iii Lp. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Cormorant Private Healthcare Fund Iii Lp's mailing address is: Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
